US FDA under fire after it forecasts work until June 2023 on final PMTA reviews

The US Food and Drug Administration (FDA) has published the first of its court-ordered regular updates on its premarket tobacco product application (PMTA) progress and it has not gone down well with health lobbyists.

The FDA said in its report that it would not finish reviewing the remaining PMTA applications until at least June 2023, a delay groups such as the Truth Initiative and the American Heart Association say will harm public health.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us